Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience

Urologic Oncology: Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.07.021Source: DataRank Database

Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience is a research paper published in Urologic Oncology: Seminars and Original Investigations (2020). On theSindex it has a DataRank of 0.515. It has been cited 30 times.

N/A

0.515DataRank · unranked

Scored on demand from live citation data

30 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 1.97)OA: closedTopics (68)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.515

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (14)

Sara Nazha,Lori A. Wood,Ricardo A. Rendon,Antonio Finelli ORCID,Aaron Hansen

Live enrichment

PubMed:32778475 OpenAlex:https://openalex.org/W3048080988

Faculty of Medicine, McGill University

FWCI

1.97

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1078143920303422?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1078143920303422?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.urolonc.2020.07.021

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32778475

Fields of Study

Renal cell carcinoma treatmentHepatocellular Carcinoma Treatment and PrognosisEconomic and Financial Impacts of CancerAgedAntineoplastic AgentsCanadaCarcinoma, Renal CellCase-Control StudiesChemotherapy, AdjuvantClinical Decision-MakingDisease ProgressionFemaleFollow-Up StudiesHumansKaplan-Meier EstimateKidneyKidney NeoplasmsMaleMetastasectomyMiddle AgedMolecular Targeted TherapyNeoplasm StagingNephrectomyPatient SelectionPrognosisSurvival RateTreatment Outcome

MeSH Terms

Clinical Decision-MakingAgedAntineoplastic AgentsCanadaCarcinoma, Renal CellFemaleFollow-Up StudiesHumansKidneyKidney NeoplasmsMaleMiddle AgedNeoplasm StagingNephrectomyPrognosisSurvival RateCase-Control StudiesTreatment OutcomeChemotherapy, AdjuvantDisease ProgressionPatient SelectionKaplan-Meier EstimateMolecular Targeted TherapyMetastasectomy

Keywords

MetastasectomyMedicineHazard ratioRenal cell carcinomaProportional hazards modelCohortMetastasisConfidence intervalKidney cancerInternal medicineOncologySurgeryCancerUrologyKidneyTargeted TherapyMetastatic Renal Cell Carcinoma

Sustainable Development Goals

SDG 0: Good health and well-being